Skip to main content

Table 1 Demographic and clinical data for OCD patients and healthy controls

From: Pharmacotherapy response and regional cerebral blood flow characteristics in patients with obsessive-compulsive disorder

Variables Pre-treatment groups (case)   Treatment remission groups (case)  
  OCD group (19) Controls (30) P SSRI (11) SSRI/quetiapine (8) P
sex (female, %) 9(47) 13(43) 0.214 5(45) 4(50) 0.305
age (years) 27.21 ± 8.75 29.25 ± 6.81 0.291 28.18 ± 8.2 26.78 ± 7.66 0.286
education (years) 12.66 ± 3.17 13.30 ± 2.47 0.667 12.12 ± 3.77 12.53 ± 3.13 0.797
length of illness (years) 2.47 ± 1.33   2.33 ± 1.99 2.97 ± 1.34 0.714
pre-treatment scales
 Y-BOCS total score 24.55 ± 6.72 11.12 ± 5.12 0.013 24.36 ± 6.22 24.55 ± 7.41 0.731
 HAMD total score 21.21 ± 4.36 16.33 ± 2.41 0.044 21.30 ± 4.11 21.00 ± 4.17 0.712
Post-treatment scales
 Y-BOCS total score 12.48 ± 5.20 *   11.51 ± 5.01 * 11.36 ± 5.14 * 0.512
 HAMD total score 17.31 ± 3.49 *   17.03 ± 3.18 * 17.21 ± 3.33 * 0.647
  1. *p < 0.01, compared to the pre-treatment score.